EXECUTIVE SUMMARY - GOLD

assessment and management of chronic
obstructive pulmonary disease (COPD). The
European Respiratory Society Task Force.
Eur Respir J 1995;8(8):1398-420.
154. American Thoracic Society. Standards for
the diagnosis and care of patients with chronic
obstructive pulmonary disease (COPD) and
asthma. Adopted by the ATS Board of
Directors, November 1986. Am Rev Respir
Dis 1987;136(1):225-44.
155. Hansen NC, Skriver A, Brorsen-Riis L,
Balslov S, Evald T, Maltbaek N, et al. Orally
administered N-acetylcysteine may improve
general well-being in patients with mild
chronic bronchitis. Respir Med
1994;88(7):531-5.
156. British Thoracic Society Research
Committee. Oral N-acetylcysteine and
exacerbation rates in patients with chronic
bronchitis and severe airways obstruction.
Thorax 1985;40(11):832-5.
157. Boman G, Backer U, Larsson S, Melander
B, Wahlander L. Oral acetylcysteine reduces
exacerbation rate in chronic bronchitis: report
of a trial organized by the Swedish Society for
Pulmonary Diseases. Eur J Respir Dis
1983;64(6):405-15.
158. Rasmussen JB, Glennow C. Reduction in
days of illness after long-term treatment with
N-acetylcysteine controlledrelease tablets in
patients with chronic bronchitis. Eur Respir J
1988;1(4):351-5.
159. Decramer M, Rutten-van Molken M,
Dekhuijzen PN, Troosters T, van Herwaarden
C, Pellegrino R, et al. Effects of N-
acetylcysteine on outcomes in chronic
obstructive pulmonary disease (Bronchitis
Randomised on NAC Cost-Utility Study,
BRONCUS): a randomised placebocontrolled
trial. Lancet 2005;365(9470):1552-
60.
160. Collet JP, Shapiro P, Ernst P, Renzi T,
Ducruet T, Robinson A. Effects of an
immunostimulating agent on acute
exacerbations and hospitalizations in patients
with chronic obstructive pulmonary disease.
The PARI-IS Study Steering Committee and
Research Group. Prevention of Acute
Respiratory Infection by an Immunostimulant.
Am J Respir Crit Care Med
1997;156(6):1719-24.
161. Li J, Zheng JP, Yuan JP, Zeng GQ, Zhong
NS, Lin CY. Protective effect of a bacterial
extract against acute exacerbation in patients
with chronic bronchitis accompanied by
chronic obstructive pulmonary disease. Chin
Med J (Engl) 2004;117(6):828-34.
162. Anthonisen NR. OM-8BV for COPD. Am
J Respir Crit Care Med 1997;156(6):1713-4.
163. Irwin RS, Boulet LP, Cloutier MM, Fuller
R, Gold PM, Hoffstein V, et al. Managing
cough as a defense mechanism and as a
symptom. A consensus panel report of the
American College of Chest Physicians. Chest
1998;114(2 Suppl Managing):133S-81S.
164. Barbera JA, Roger N, Roca J, Rovira I,
Higenbottam TW, Rodriguez-Roisin R.
Worsening of pulmonary gas exchange with
nitric oxide inhalation in chronic obstructive
pulmonary disease. Lancet
1996;347(8999):436-40.
165. Jones AT, Evans TW. NO: COPD and
beyond. Thorax 1997;52 Suppl 3:S16-21.